A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2006
10/12/2006	US20060228328 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins
10/12/2006	US20060228327 administration of an effective amount of a CC-chemokine mutant having reduced glycosaminoglycan (GAG)-binding activity as compared to the wild type peptide to a subject with hepatitis; counteracts liver fibrotic injury
10/12/2006	US20060228326 Active specific immunotherapy of cancer metastasis
10/12/2006	US20060228299 Constructs binding to phosphatidylserine and their use in disease treatment
10/12/2006	US20060228296 Method of screening groups of radioactive molecules and applications thereof
10/12/2006	DE102005016234A1 In vitro infiltration of extracelluar antigens into the major histocompability complex class I-presentation pathway of cells, comprises determining specific parameters for antigen presenting cells, and transmitting the determined parameters
10/12/2006	CA2608165A1 Dermopharmaceutical or cosmetic composition comprising enkephalin-derived peptides for reducing and/or eliminating facial wrinkles
10/12/2006	CA2603970A1 Methods for treating immune disorders associated with graft transplantation with soluble ctla4 mutant molecules
10/12/2006	CA2603896A1 Bone cement compositions and the like comprising an rnaiii-inhibiting peptide
10/12/2006	CA2603808A1 Treatment of asthma
10/12/2006	CA2603805A1 Use of rip in treating staphylococcus aureus infections
10/12/2006	CA2603642A1 Compositions and methods for the inhibition of dishevelled proteins
10/12/2006	CA2603452A1 Tripeptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1
10/12/2006	CA2603245A1 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
10/12/2006	CA2603016A1 Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device
10/12/2006	CA2602850A1 Ocular delivery of interferon-tau
10/11/2006	EP1710582A2 Suppressor genes
10/11/2006	EP1710314A1 Humanized immunoglobulin reactive with alpha4beta7 integrin
10/11/2006	EP1710307A2 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
10/11/2006	EP1710304A1 Process for producing polymer composite of protein
10/11/2006	EP1710254A2 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
10/11/2006	EP1710252A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/11/2006	EP1710251A1 Novel peptide, process for producing the same and pharmaceutical composition containing the peptide
10/11/2006	EP1709995A1 Asthma/allergy therapy using nigella sativa
10/11/2006	EP1709976A1 Emt- inducing agents
10/11/2006	EP1709970A1 Human antibodies against EGFR, derived from immunized xenomice
10/11/2006	EP1709450A2 Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof
10/11/2006	EP1709196A2 Use of fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders
10/11/2006	EP1709177A2 Dna-sequence and recombinant production of group 4 major allergens from cereals
10/11/2006	EP1709175A2 Hif oligonucleotide decoy molecules
10/11/2006	EP1709161A2 Human therapeutic cells secreting nerve growth factor
10/11/2006	EP1709084A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins
10/11/2006	EP1709075A2 Treatment of viral infections
10/11/2006	EP1709072A1 Variants of the extracellular domain of bcma and uses thereof
10/11/2006	EP1709071A1 Glucagon-like peptide-1 analogs with long duration of action
10/11/2006	EP1709066A1 Inclusion complexes of perindopril
10/11/2006	EP1709047A2 Azabenzofuran substituted thioureas as inhibitors of viral replication
10/11/2006	EP1708755A2 Transglutaminase mediated conjugation of peptides
10/11/2006	EP1708753A1 Use of goat serum for veterinary treatment
10/11/2006	EP1708740A1 Protease inhibitors for the treatment of digestive pathologies
10/11/2006	EP1708739A1 Neuroprotective complex for treatment of cerebral ischemia and injury
10/11/2006	EP1708738A1 A method of reducing serum proinsulin levels in type 2 diabetics
10/11/2006	EP1708737A2 Use of interleukin-21 for the treatment of autoimmune diseases and allograft rejection
10/11/2006	EP1708736A1 Means for stimulation and activation of hair growth by il-15
10/11/2006	EP1708735A1 Antimicrobial composition
10/11/2006	EP1708734A1 HIV gp41 HR2-DERIVED SYNTHETIC PEPTIDES, AND THEIR USE IN THERAPY TO INHIBIT TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS
10/11/2006	EP1708733A1 Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension
10/11/2006	EP1708732A2 Synthetic hla binding peptide analogues and uses thereof
10/11/2006	EP1708731A2 Neuroprotective dietary supplement
10/11/2006	EP1708730A2 Use of a dg147 protein product for preventing and treating metabolic disorders
10/11/2006	EP1622929B1 Apo2l (trail) receptor binding peptides and uses thereof
10/11/2006	EP1546362A4 Apolipoprotein e stable folding intermediate and methods of use thereof
10/11/2006	EP1536688A4 Mammalian megakaryocyte progenitor cell
10/11/2006	EP1469741B1 A process for the extraction,purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent
10/11/2006	EP1432730A4 Glucagon-like peptide-1 analogs
10/11/2006	EP1430045B1 Pyrane derivatives as both ace- and nep-inhibitors
10/11/2006	EP1348024B1 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
10/11/2006	EP1299091B1 Matrix controlled transdermal system for stabile derivatives of ace inhibitors
10/11/2006	EP1276505B1 Mixtures of triblock polyesterpolyethylene glycol copolymers
10/11/2006	EP1250600B1 Diagnosis of tauopathies determining tau/phospho-tau ratio
10/11/2006	EP1226212B1 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof
10/11/2006	EP1181013B1 Method and composition for the treatment of cancer
10/11/2006	EP1173476B1 Soybean protein nutraceuticals
10/11/2006	EP1147134B1 Novel potassium channels and genes encoding these potassium channels
10/11/2006	EP1140149B1 Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment
10/11/2006	EP1133311B1 INFLUENCING ANGIOGENESIS USING CD66a
10/11/2006	EP1071792B1 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
10/11/2006	EP1070118B1 Modified adenovirus containing a fiber replacement protein
10/11/2006	EP1049465B1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
10/11/2006	EP0998307B1 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF
10/11/2006	EP0972041B1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/11/2006	EP0968230B1 Oxidized fragments of apolipoprotein b and their use
10/11/2006	EP0954565B1 Adipogenic differentiation of human mesenchymal stem cells
10/11/2006	EP0914448B1 Lipid kinase
10/11/2006	EP0896586B1 ErbB3 ANTIBODIES
10/11/2006	EP0842209B1 Multiblock biodegradable hydrogels for use as controlled release agents for drugs and tissue treatment agents
10/11/2006	EP0832225B1 Chimeric proteins for use in transport of a selected substance into cells
10/11/2006	EP0804479B1 Method of treating diabetes mellitus using kgf
10/11/2006	EP0760672B1 Angiotensin ii for improving fertilization
10/11/2006	EP0751782B1 Use of a non-neutralizing antibody specific for the beta-subunit of luteinizing hormone for enhancing fertility
10/11/2006	EP0668777B1 Prostate-specific membrane antigen
10/11/2006	CN1846000A HPV CD8+ T-cell epitopes
10/11/2006	CN1845995A Chimeric antigens for breaking host tolerance to foreign antigens
10/11/2006	CN1845936A Ra antigenic peptides
10/11/2006	CN1845920A 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease
10/11/2006	CN1845757A Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture
10/11/2006	CN1845753A Liquid, aqueous, pharmaceutical compositions of factor vii polypeptides
10/11/2006	CN1845752A Use of soluble cd164 in inflammatory and/or autoimmune disorders
10/11/2006	CN1845751A Stationary phases and a purification process using the stationary phases
10/11/2006	CN1845748A Fish protein hydrolyzate
10/11/2006	CN1844925A Method for determining bioactivity of recombinant insulin secretagogue and application thereof
10/11/2006	CN1844406A Method for preparing antihypertensive peptides by using proteins in shrimps
10/11/2006	CN1844391A Nucleotide sequence for human morphogenetic protein 9 recombinant proteins and production method and use thereof
10/11/2006	CN1843505A Compound Doxycycline lysozyme enteral capsule
10/11/2006	CN1843504A Albumin nanosphere medicine composition and its preparation method and application method
10/11/2006	CN1843503A Eye drops
10/11/2006	CN1843502A Active bone peptide for treating and preventing osteoporosis and its preparing method
10/11/2006	CN1843384A Tetraselmis chui polysaccharide protein possessing antineoplastic function
10/11/2006	CN1279170C Encoding gene sequence of nereid kinase possessing embolus dissolving activity and its amino acid sequence
10/11/2006	CN1279168C Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them

1 ... 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 ... 3163